Take a look at the chart below. Pfizer’s stock (PFE) is valued at 25% less than it was five years ago. This has happened despite the billions of dollars it received from the sales of COVID vaccines. Not only that but the stock market and the pharmaceuticals index have not tracked with Pfizer. Just what is going on?
On the surface, Pfizer should not be worth less than before the COVID scamdemic hit. Pfizer’s “vaccine” made billions of dollars for the company. So, why the decline in stock value?
Has Wall Street awakened to the possibility that Pfizer may be significantly exposed to COVID liability claims relating to the mRNA “vaccine?” Did Pfizer dishonestly market a harmful product in the mRNA “vaccine?”
Many people know that Big Pharma cannot be sued for a product that receives “Emergency Use Authorization (EUA).” However, decoupling a company’s profit interest from its interest in safety creates a moral hazard. This departs from centuries of product liability doctrine. As it turns out, that immunity is not ironclad. The legal protection granted to Pfizer by the PREP act will cease to protect it if significant fraud on the part of Pfizer is discovered.
Pfizer’s peak stock value appears to have occurred in the December 2020-January 2021 timeframe. Did something happen at this point in time that caused Wall Street to take a more careful look at the Pfizer situation?
There was considerable noise about deleterious side effects including deaths before this. However, the media and the government had been somewhat successful in suppressing negative info about the jabs. Did something happen during this time frame that changed the landscape from Wall Street’s point of view?
Buried in the noise of the January 6th “insurrection,” a federal judge in the North District of Texas, Mark Pittman, found the FDA’s claim that it could not produce more than 500 pages a month of data on the development of the “vaccine” unreasonable. The judge on Jan. 6 ordered the FDA to produce at least 55,000 pages per month.
As this data has been produced, Pfizer’s stock value has been in decline. Coincidence? I think not.
The gold standard for drug development is what is known as “all cause mortality (ACM)”. It is a fact that ACM was higher for people who received the Pfizer jab in the trials than those who received the placebo. Just what else is there in the volumes of data that have been released?
If the stock price of Pfizer is any guide, the capital markets see that bankruptcy may be on the horizon for Pfizer. Regardless of the billions that were made, Pfizer will never have enough money to fairly compensate those who suffered from the mRNA jab.
Igor Chudov asks this question. “Are Google and Facebook also liable? After all, they intentionally conspired to hide the dangers of the COVID vaccines from the public. This is undoubtedly a long shot.” However, the more that the serious consequences of the jabs seeps out into the public, the greater the possibility becomes that some real justice will be found.